Ran Barzilay1, Monica E Calkins2, Tyler M Moore3, Rhonda C Boyd4, Jason D Jones5, Tami D Benton6, Maria A Oquendo7, Ruben C Gur8, Raquel E Gur9. 1. Research Scientist, Lifespan Brain Institute, Children's Hospital of Philadelphia and Penn Medicine; and Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, USA. 2. Associate Professor, Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA. 3. Research Associate, Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA. 4. Associate Professor, Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, USA. 5. Research Scientist, Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, USA. 6. Associate Professor, Chair of the Department of Child and Adolescent Psychiatry and Behavioral Sciences, Children's Hospital of Philadelphia, USA. 7. Professor, Chair of the Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA. 8. Professor, Lifespan Brain Institute, Children's Hospital of Philadelphia and Penn Medicine; and Director of Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA. 9. Professor, Director of Lifespan Brain Institute, Children's Hospital of Philadelphia and Penn Medicine; and Neuropsychiatry Section, Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, USA.
Abstract
BACKGROUND: Although there are extensive data on clinical psychopathology in youth with suicidal ideation, data are lacking regarding their neurocognitive function. AIMS: To characterise the cognitive profile of youth with suicidal ideation in a community sample and evaluate gender differences and pubertal status effects. METHOD: Participants (N = 6151, age 11-21 years, 54.9% females) from the Philadelphia Neurodevelopmental Cohort, a non-help-seeking community sample, underwent detailed clinical evaluation. Cognitive phenotyping included executive functioning, episodic memory, complex reasoning and social cognitive functioning. We compared participants with suicidal ideation (N = 672) and without suicidal ideation (N = 5479). Regression models were employed to evaluate differences in cognitive performance and functional level, with gender and pubertal status as independent variables. Models controlled for lifetime depression or general psychopathology, and for covariates including age and socioeconomic status. RESULTS: Youth with suicidal ideation showed greater psychopathology, poorer level of function but better overall neurocognitive performance. Greater functional impairment was observed in females with suicidal ideation (suicidal ideation × gender interaction, t = 3.091, P = 0.002). Greater neurocognition was associated with suicidal ideation post-puberty (suicidal ideation × puberty interaction, t = 3.057, P = 0.002). Exploratory analyses of specific neurocognitive domains showed that suicidal ideation-associated cognitive superiority was more prominent in post-pubertal males compared with females (Cohen's d = 0.32 and d = 0.11, respectively) across all cognitive domains. CONCLUSIONS: Suicidal ideation was associated with poorer functioning yet better cognitive performance, especially in post-pubertal males, as measured by a comprehensive cognitive battery. Findings point to gender and pubertal-status specificity in the relationship between suicidal ideation, cognition and function in youth. DECLARATION OF INTEREST: R.B. serves on the scientific board and reports stock ownership in 'Taliaz Health', with no conflict of interest relevant to this work. M.A.O. receives royalties for the commercial use of the Columbia-Suicide Severity Rating Scale from the Research Foundation for Mental Hygiene. Her family owns stock in Bristol-Myers Squibb. All other authors declare no potential conflict of interest.
BACKGROUND: Although there are extensive data on clinical psychopathology in youth with suicidal ideation, data are lacking regarding their neurocognitive function. AIMS: To characterise the cognitive profile of youth with suicidal ideation in a community sample and evaluate gender differences and pubertal status effects. METHOD:Participants (N = 6151, age 11-21 years, 54.9% females) from the Philadelphia Neurodevelopmental Cohort, a non-help-seeking community sample, underwent detailed clinical evaluation. Cognitive phenotyping included executive functioning, episodic memory, complex reasoning and social cognitive functioning. We compared participants with suicidal ideation (N = 672) and without suicidal ideation (N = 5479). Regression models were employed to evaluate differences in cognitive performance and functional level, with gender and pubertal status as independent variables. Models controlled for lifetime depression or general psychopathology, and for covariates including age and socioeconomic status. RESULTS: Youth with suicidal ideation showed greater psychopathology, poorer level of function but better overall neurocognitive performance. Greater functional impairment was observed in females with suicidal ideation (suicidal ideation × gender interaction, t = 3.091, P = 0.002). Greater neurocognition was associated with suicidal ideation post-puberty (suicidal ideation × puberty interaction, t = 3.057, P = 0.002). Exploratory analyses of specific neurocognitive domains showed that suicidal ideation-associated cognitive superiority was more prominent in post-pubertal males compared with females (Cohen's d = 0.32 and d = 0.11, respectively) across all cognitive domains. CONCLUSIONS: Suicidal ideation was associated with poorer functioning yet better cognitive performance, especially in post-pubertal males, as measured by a comprehensive cognitive battery. Findings point to gender and pubertal-status specificity in the relationship between suicidal ideation, cognition and function in youth. DECLARATION OF INTEREST: R.B. serves on the scientific board and reports stock ownership in 'Taliaz Health', with no conflict of interest relevant to this work. M.A.O. receives royalties for the commercial use of the Columbia-Suicide Severity Rating Scale from the Research Foundation for Mental Hygiene. Her family owns stock in Bristol-Myers Squibb. All other authors declare no potential conflict of interest.
Authors: J Kaufman; B Birmaher; D Brent; U Rao; C Flynn; P Moreci; D Williamson; N Ryan Journal: J Am Acad Child Adolesc Psychiatry Date: 1997-07 Impact factor: 8.829
Authors: Theodore D Satterthwaite; Russell T Shinohara; Daniel H Wolf; Ryan D Hopson; Mark A Elliott; Simon N Vandekar; Kosha Ruparel; Monica E Calkins; David R Roalf; Efstathios D Gennatas; Chad Jackson; Guray Erus; Karthik Prabhakaran; Christos Davatzikos; John A Detre; Hakon Hakonarson; Ruben C Gur; Raquel E Gur Journal: Proc Natl Acad Sci U S A Date: 2014-05-27 Impact factor: 11.205
Authors: J G Keilp; M Gorlyn; M Russell; M A Oquendo; A K Burke; J Harkavy-Friedman; J J Mann Journal: Psychol Med Date: 2012-07-10 Impact factor: 7.723
Authors: Sheila Shanmugan; Daniel H Wolf; Monica E Calkins; Tyler M Moore; Kosha Ruparel; Ryan D Hopson; Simon N Vandekar; David R Roalf; Mark A Elliott; Chad Jackson; Efstathios D Gennatas; Ellen Leibenluft; Daniel S Pine; Russell T Shinohara; Hakon Hakonarson; Ruben C Gur; Raquel E Gur; Theodore D Satterthwaite Journal: Am J Psychiatry Date: 2016-01-22 Impact factor: 18.112
Authors: Catherine M Herba; Robert F Ferdinand; Jan van der Ende; Frank C Verhulst Journal: J Am Acad Child Adolesc Psychiatry Date: 2007-11 Impact factor: 8.829
Authors: Helen Z Reinherz; Jennifer L Tanner; Sasha R Berger; William R Beardslee; Garrett M Fitzmaurice Journal: Am J Psychiatry Date: 2006-07 Impact factor: 19.242
Authors: Antonia N Kaczkurkin; Aristeidis Sotiras; Erica B Baller; Ran Barzilay; Monica E Calkins; Ganesh B Chand; Zaixu Cui; Guray Erus; Yong Fan; Raquel E Gur; Ruben C Gur; Tyler M Moore; David R Roalf; Adon F G Rosen; Kosha Ruparel; Russell T Shinohara; Erdem Varol; Daniel H Wolf; Christos Davatzikos; Theodore D Satterthwaite Journal: Biol Psychiatry Date: 2019-09-18 Impact factor: 13.382
Authors: Ran Barzilay; Tyler M Moore; Monica E Calkins; Lydia Maliackel; Jason D Jones; Rhonda C Boyd; Varun Warrier; Tami D Benton; Maria A Oquendo; Ruben C Gur; Raquel E Gur Journal: Neurobiol Stress Date: 2021-03-10
Authors: Jason D Jones; Rhonda C Boyd; Monica E Calkins; Tyler M Moore; Annisa Ahmed; Ran Barzilay; Tami D Benton; Raquel E Gur; Ruben C Gur Journal: J Child Psychol Psychiatry Date: 2020-03-30 Impact factor: 8.982